Literature DB >> 17932490

The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1.

Bekir Cinar1, Ping-Ke Fang, Mohini Lutchman, Dolores Di Vizio, Rosalyn M Adam, Natalya Pavlova, Mark A Rubin, Pamela C Yelick, Michael R Freeman.   

Abstract

Akt kinases mediate cell growth and survival. Here, we report that a pro-apoptotic kinase, Mst1/STK4, is a physiological Akt1 interaction partner. Mst1 was identified as a component of an Akt1 multiprotein complex isolated from lipid raft-enriched fractions of LNCaP human prostate cancer cells. Endogenous Mst1, along with its paralog, Mst2, acted as inhibitors of endogenous Akt1. Surprisingly, mature Mst1 as well as both of its caspase cleavage products, which localize to distinct subcellular compartments and are not structurally homologous, complexed with and inhibited Akt1. cRNAs encoding full-length Mst1, and N- and C-terminal caspase Mst1 cleavage products, reverted an early lethal phenotype in zebrafish development induced by expression of membrane-targeted Akt1. Mst1 and Akt1 localized to identical subcellular sites in human prostate tumors. Mst1 levels declined with progression from clinically localized to hormone refractory disease, coinciding with an increase in Akt activation with transition from hormone naïve to hormone-resistant metastases. These results position Mst1/2 within a novel branch of the phosphoinositide 3-kinase/Akt pathway and suggest an important role in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932490      PMCID: PMC2063482          DOI: 10.1038/sj.emboj.7601872

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

Review 1.  Regulation of the Akt kinase by interacting proteins.

Authors:  Keyong Du; Philip N Tsichlis
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

2.  Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT.

Authors:  Merav Yoeli-Lerner; Gary K Yiu; Isaac Rabinovitz; Peter Erhardt; Sebastien Jauliac; Alex Toker
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

3.  Identification of a tumour suppressor network opposing nuclear Akt function.

Authors:  Lloyd C Trotman; Andrea Alimonti; Pier Paolo Scaglioni; Jason A Koutcher; Carlos Cordon-Cardo; Pier Paolo Pandolfi
Journal:  Nature       Date:  2006-05-07       Impact factor: 49.962

4.  RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network.

Authors:  Cai Guo; Stella Tommasi; Limin Liu; Jiing-Kuan Yee; Reinhard Dammann; Gerd P Pfeifer
Journal:  Curr Biol       Date:  2007-03-22       Impact factor: 10.834

Review 5.  Akt-regulated pathways in prostate cancer.

Authors:  Pradip K Majumder; William R Sellers
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

6.  Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB.

Authors:  Dos D Sarbassov; Siraj M Ali; Shomit Sengupta; Joon-Ho Sheen; Peggy P Hsu; Alex F Bagley; Andrew L Markhard; David M Sabatini
Journal:  Mol Cell       Date:  2006-04-06       Impact factor: 17.970

7.  AKT can be activated in the nucleus.

Authors:  Ruiwen Wang; Michael G Brattain
Journal:  Cell Signal       Date:  2006-02-28       Impact factor: 4.315

8.  Loss of PTEN is associated with progression to androgen independence.

Authors:  Jerod Bertram; James W Peacock; Ladan Fazli; Alice L-F Mui; Stephen W Chung; Michael E Cox; Brett Monia; Martin E Gleave; Christopher J Ong
Journal:  Prostate       Date:  2006-06-15       Impact factor: 4.104

9.  Role of the tumor suppressor RASSF1A in Mst1-mediated apoptosis.

Authors:  Hyun Jung Oh; Kyung-Kwon Lee; Su Jung Song; Mi Sun Jin; Min Sup Song; Joo Hyun Lee; Chang Rak Im; Jie-Oh Lee; Shin Yonehara; Dae-Sik Lim
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

10.  Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition.

Authors:  Hanna Y Irie; Rachel V Pearline; Dorre Grueneberg; Maximilian Hsia; Preethi Ravichandran; Nayantara Kothari; Sridaran Natesan; Joan S Brugge
Journal:  J Cell Biol       Date:  2005-12-19       Impact factor: 10.539

View more
  64 in total

1.  MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.

Authors:  Bekir Cinar; Filiz Kisaayak Collak; Delia Lopez; Seckin Akgul; Nishit K Mukhopadhyay; Murat Kilicarslan; Daniel G Gioeli; Michael R Freeman
Journal:  Cancer Res       Date:  2011-04-21       Impact factor: 12.701

2.  Redemystifying MST1/hippo signaling.

Authors:  Lei Xiao; Zengqiang Yuan
Journal:  Protein Cell       Date:  2010-08       Impact factor: 14.870

3.  Deacetylation of tumor-suppressor MST1 in Hippo pathway induces its degradation through HBXIP-elevated HDAC6 in promotion of breast cancer growth.

Authors:  L Li; R Fang; B Liu; H Shi; Y Wang; W Zhang; X Zhang; L Ye
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

4.  Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer.

Authors:  Sun-Hye Jeong; Han-Byul Kim; Min-Chul Kim; Ji-Min Lee; Jae Ho Lee; Jeong-Hwan Kim; Jin-Woo Kim; Woong-Yang Park; Seon-Young Kim; Jae Bum Kim; Haeryoung Kim; Jin-Man Kim; Hueng-Sik Choi; Dae-Sik Lim
Journal:  J Clin Invest       Date:  2018-02-05       Impact factor: 14.808

5.  An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.

Authors:  Dolores Di Vizio; Matteo Morello; Federica Sotgia; Richard G Pestell; Michael R Freeman; Michael P Lisanti
Journal:  Cell Cycle       Date:  2009-08-27       Impact factor: 4.534

Review 6.  MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.

Authors:  Amin Ardestani; Kathrin Maedler
Journal:  Diabetologia       Date:  2016-04-06       Impact factor: 10.122

7.  Regulation of proapoptotic mammalian ste20-like kinase MST2 by the IGF1-Akt pathway.

Authors:  Donghwa Kim; Shaokun Shu; Marc D Coppola; Satoshi Kaneko; Zeng-Qiang Yuan; Jin Q Cheng
Journal:  PLoS One       Date:  2010-03-09       Impact factor: 3.240

8.  Structural comparison of human mammalian ste20-like kinases.

Authors:  Christopher J Record; Apirat Chaikuad; Peter Rellos; Sanjan Das; Ashley C W Pike; Oleg Fedorov; Brian D Marsden; Stefan Knapp; Wen Hwa Lee
Journal:  PLoS One       Date:  2010-08-06       Impact factor: 3.240

9.  Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.

Authors:  Zengqiang Yuan; Donghwa Kim; Shaokun Shu; Junbing Wu; Jianping Guo; Lei Xiao; Satoshi Kaneko; Domenico Coppola; Jin Q Cheng
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

10.  Mst1-FoxO signaling protects Naïve T lymphocytes from cellular oxidative stress in mice.

Authors:  Juhyun Choi; Sangphil Oh; Dongjun Lee; Hyun Jung Oh; Jik Young Park; Sean Bong Lee; Dae-Sik Lim
Journal:  PLoS One       Date:  2009-11-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.